Check-Cap Advances MBody AI Merger with 1-for-7 Reverse Share Split

Corporate Action
โดย GlobeNewswire·IL·Read original
Summary · why it matters

Check-Cap Ltd. has completed a 1-for-7 reverse share split effective August 13, 2026, advancing its proposed merger with physical AI company MBody AI Corp. The reverse split reduces outstanding ordinary shares from approximately 9,463,062 to approximately 1,351,866, with every seven shares consolidated into one and no fractional shares issued, as fractional shares are rounded up to the nearest whole share. The company's ordinary shares begin trading on a split-adjusted basis on The Nasdaq Capital Market under the symbol MBAI and new CUSIP number M6S83C106. The move is a shareholder-approved step to position the combined company to satisfy the $4.00 minimum bid price standard for its initial listing application with Nasdaq, and the merger remains on track to close in the third quarter of 2026, subject to final Nasdaq approval and customary closing conditions.

Impact on stocks 1

Biotech & Genomic Medicine · 1 stocks
Check-Cap Ltd.
MBAI
▲ PositiveCapitalrelevance

Reverse split and merger progress support Nasdaq listing and future valuation.

Off-coverage companies 1

MBody AI CorpPrivate▲ Positive
Capitalrelevance

Merger with Check-Cap advances, positioning MBody AI for public listing.